IRadimed Corp reports results for the quarter ended June 30 - Earnings Summary

• IRadimed Corp IRMD reported quarterly adjusted earnings of 49 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of 42 cents. The mean expectation of two analysts for the quarter was for earnings of 44 cents per share. Wall Street expected results to range from 42 cents to 45 cents per share.

• Revenue rose 13.8% to $20.41 million from a year ago; analysts expected $20.01 million.

• IRadimed Corp's reported EPS for the quarter was 45 cents​.

• The company reported quarterly net income of $5.77 million.

• IRadimed Corp shares had fallen by 2.4% this quarter and gained 6.1% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts was unchanged in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"

• Wall Street's median 12-month price target for IRadimed Corp is $71.00, about 17.8% above its last closing price of $58.34

This summary was machine generated from LSEG data August 1 at 01:32 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)